Announcements Trials

Browse Landscape

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 12 Squamous Cell Carcinoma of Head and Neck 7 Head and Neck Neoplasms 5 Uterine Cervical Neoplasms 4 Stomach Neoplasms 4 Nasopharyngeal Carcinoma 4 Ovarian Neoplasms 3 Uterine Cervical Dysplasia 2 Small Cell Lung Carcinoma 2 Neoplasms 2 Malnutrition 2 Lung Neoplasms 2 Biliary Tract Neoplasms 2 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Salivary Gland Neoplasms 1 Recurrence 1 Pseudomyxoma Peritonei 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Ototoxicity 1 Oropharyngeal Neoplasms 1 Neurotoxicity Syndromes 1 Neoplastic Cells, Circulating 1 Neoplasms, Second Primary 1 Mesothelioma 1 Lymphoma, Non-Hodgkin 1 Liver Neoplasms 1 Kidney Diseases 1 Gallbladder Neoplasms 1

Interventions

Drug Therapy 2 Tyrosine Kinase Inhibitors 1 Trastuzumab 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Semen Analysis 1 Registries 1 Radiotherapy 1 Patient Reported Outcome Measures 1 Lenalidomide 1 Interviews as Topic 1 Data Collection 1 Cisplatin 1 Choledochostomy 1 Bleomycin 1 Anthracyclines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neoplasms, Second Primary × Cisplatin × Clear all

NCT03199300 2025-12-11

InvestiCAT

University Medical Center Groningen

Active not recruiting

Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡